Today, the CEO of Xoma Corp (XOMA), James Neal, bought shares of XOMA for $53.04K.
This recent transaction increases James Neal’s holding in the company by 20.73% to a total of $312.4K. This is Neal’s first Buy trade following 6 Sell transactions.
See today’s analyst top recommended stocks >>
The Company has a Price to Book ratio of 97.5486. Currently, Xoma Corp has an average volume of 95.96K.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.
